ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 94037 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 94037; 2) Community: the network communities that were significantly associated with the response to NSC 94037; 3) Molecule: the relationships between components within communities and NSC 94037; 4) MDR: the compounds that were significantly associated with the NSC 94037.

NSC Compound Enrichment Correlation
NSC 659936 Null 0.0123744972338279 0.66933204
NSC 662784 Null 0.0123744972338279 0.60739953
NSC 679005 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester 0.0123744972338279 0.7724183
NSC 69852 1,4-Butanediamine, N,N'-bis(3-aminopropyl)-, tetrahydrochloride (8CI9CI) 0.0123744972338279 0.63880202
NSC 704888 Fumaric acid, 2-[5-chloro-3-(2-ethoxy-2-oxoethyl)-2,4-dioxo- 1H,3H-pyrimidinyl]-, diethyl ester 0.0123744972338279 0.7650201
NSC 709100 Null 0.0123744972338279 0.27541649
NSC 742838 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl-, hydrochloride 0.0123744972338279 0.51231647
NSC 743244 Null 0.0123744972338279 0.35056639
NSC 105132 Deoxycamptothecin 0.0133299224082803 -0.026599658
NSC 130279 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) 0.0133299224082803 0.38300832
Total:88  Current:34    [First] [Prev] [Next] [Last]